“We invite all IASLC members, health care professionals and other interested parties to take this survey, and to share the survey with their colleagues and professional networks. Your participation is critical for us to understand the current status of molecular testing in lung cancer as well as the regional challenges and barriers to implementation.”
The survey is available in English, Chinese, Japanese, Portuguese and Spanish.
The survey results will be presented at an upcoming IASLC meeting, submitted for publication to the official journal of the IASLC, the Journal of Thoracic Oncology, and inform strategies that regions and countries could implement to overcome barriers to molecular testing in lung cancer patients.
All respondents will be entered into a drawing to win free registration (five total) to an upcoming IASLC World Conference on Lung Cancer.
If you have any questions about survey, or if you wish to contact the IASLC about this important activity, please feel free to email email@example.com or call +1.720.598.1949.